A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Pancreatic Ductal Adenocarcinoma
Related studies linked through entity extraction aliases.
Safety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With Metastatic Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE3
IBI343 in Combination Therapy for Advanced Malignant Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy
- Status
- RECRUITING
- Phase
- NA
A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer
- Status
- RECRUITING
- Phase
- NA
TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
PRetreatment MRI for OCcult Liver Metastasis Assessment In Pancreatic Ductal adenocarcinoMa
- Status
- RECRUITING
- Phase
- N/A
Prognostic Outcomes of Total Mesopancreas Excision for Pancreatic Head Cancer
- Status
- RECRUITING
- Phase
- NA
Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer
- Status
- RECRUITING
- Phase
- N/A
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Maintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Monthly Alternating NALIRIFOX and GnP in the First-Line Setting for Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas
- Status
- RECRUITING
- Phase
- PHASE3